Both in Pharmaceuticals
Kardigan vs Korsana Biosciences
Over the past year KARD returned −23.3% and KRSA returned −0.8%; their daily moves had a correlation of 0.05.
KARD −23.3% KRSA −0.8%Growth of $1, one year, split-adjusted
| Metric | KARD | KRSA |
|---|---|---|
| Price | $14.21 | $31.66 |
| Market cap | $1.33B | $1.44B |
| Today | +0.57% | +5.04% |
| 1 month | −3.9% | +3.8% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $597.6M | — |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 13.8% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).